Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A August

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Journal of Pancreatic Cancer|August 9, 2020
Subcategorizing T1 Staging in Pancreatic Adenocarcinoma Predicts Survival in Patients Undergoing Resection: An Analysis of the National Cancer DatabaseMihir M Shah, Rachel E NeMoyer, Stephanie H Greco, et al.
Surgery Open Science|January 25, 2021
Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer DatabaseStephanie H Greco, David A August, Mihir M Shah, et al.
Cancer Medicine|January 8, 2024
Recurrence-free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trialsEmma Vail, Ankur P Choubey, H Richard Alexander, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapyShane S Neibart, Swati Mamidanna, Anupama Chundury, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Journal of Pancreatic Cancer|August 9, 2020
Subcategorizing T1 Staging in Pancreatic Adenocarcinoma Predicts Survival in Patients Undergoing Resection: An Analysis of the National Cancer DatabaseMihir M Shah, Rachel E NeMoyer, Stephanie H Greco, et al.
Surgery Open Science|January 25, 2021
Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: An analysis of the National Cancer DatabaseStephanie H Greco, David A August, Mihir M Shah, et al.
Cancer Medicine|January 8, 2024
Recurrence-free survival dynamics following adjuvant chemotherapy for resected colorectal cancer: A systematic review of randomized controlled trialsEmma Vail, Ankur P Choubey, H Richard Alexander, et al.
Journal of Gastrointestinal Oncology|January 24, 2022
Outcomes of patients with borderline resectable and resectable pancreatic adenocarcinoma treated with neoadjuvant three-week course chemoradiotherapy using capecitabine-based versus gemcitabine-based concurrent chemotherapyShane S Neibart, Swati Mamidanna, Anupama Chundury, et al.
Pageof 7